Adding Tgf Beta To Jurkat Assay

Human Latent TGF beta-1 Flow Cytomtery Assay

HX87434 96 tests
EUR 270

Human IgG antibody Laboratories manufactures the adding tgf beta to jurkat assay reagents distributed by Genprice. The Adding Tgf Beta To Jurkat Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact tgf assay. Other Adding products are available in stock. Specificity: Adding Category: Tgf Group: Beta To

TGF beta Antibody

0.1 mg Ask for price

TGF beta Antibody

0.1 mg Ask for price

TGF beta Antibody

0.01 mg Ask for price

TGF beta Antibody

0.05 mg Ask for price

TGF beta Antibody

0.25 mg Ask for price

TGF beta

100 ul.
EUR 295.2

Human TGF-beta-3 Antibody

150 ug
EUR 215

Beta To information

Jurkat cell Lysate (untreated)

2401-100 each
EUR 222

Jurkat Cell Extract (Uninduced)

1106-1000 each
EUR 379.2

Jurkat Cell Extract (Uninduced)

1106-400 each
EUR 222

OCPB00177-100UG - Jurkat Lysate

OCPB00177-100UG 0.1mg
EUR 139

CRISPRa (SAM) Jurkat Cell Pool

78080 2 million cells
EUR 795
Description: This cell line has been engineered for use with the CRISPR Synergistic Activation Mediator (SAM) system to induce transcriptional activation and expression of any gene of interest. Cells stably express a mutated dCas9 (Streptococcus pyogenes CRISPR associated protein 9), lacking any endonuclease activity, fused to VP64, a transcriptional activator. Stable dCas9-VP64 expression is maintained with Blasticidin resistance. Cells also stably express P65 (Transcription Factor p65, or Nuclear Factor NF-κB p65) and HSF1 (Heat Shock Factor 1) fused with an MS2 tag, which is maintained with Hygromycin resistance. When these cells are transfected with an MS2-tagged sgRNA targeting the promoter region of the gene of interest, dCas9-VP64 and MS2-P65-HSF1 are recruited to the site in the genomic DNA and begin transcription, inducing expression of the desired gene.

Jurkat-Lucia™ NFAT Cells

jktl-nfat 3-7 x 10e6 cells
EUR 1289.4

B2M Knockout Jurkat Cell Line

78342 2 vials
EUR 6500
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from Jurkat cells.

TCR Knockout Jurkat Cell Line

78539 2 vials
EUR 6500
Description: The TCR Knockout Jurkat cell line was generated by CRISPR/Cas9 genome editing to remove the TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα and β chains.

JURKAT FFPE Cell Pellet Block

LeFFPE-CP007 1 Block Ask for price
Description: Leukemia

Human Jurkat Whole Cell Lysate

LYSATE0027 200ug
EUR 180
Description: This cell lysate is prepared from human Jurkat using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C.

Human Jurkat Whole Cell Lysate

EUR 327
Description: Human Jurkat Whole Cell Lysate

JURKAT FFPE Cell Pellet Slides

LeFFPE-CP008 5 Slides Ask for price
Description: Leukemia

STAT3 Reporter Jurkat Cell Line

78497 2 vials
EUR 1900
Description: The STAT3 Reporter Jurkat cell line is designed for monitoring the STAT3 signal transduction pathway. It contains a firefly luciferase gene driven by STAT3 response elements located upstream of the minimal TATA promoter. After activation by cytokines or growth factors, endogenous STAT3 binds to the DNA response elements, inducing transcription of the luciferase reporter gene.

JURKAT FFPE Cell Pellet Scrolls

LeFFPE-CP009 5 Scrolls Ask for price
Description: Leukemia

Cas9 Expressing Jurkat Cell Line

T3261 1x10^6 cells / 1.0 ml
EUR 795

Jurkat, Clone E6-1 Cell Line

CL-0129 1×10⁶ cells/vial
EUR 420
Description: Homo sapiens, Human

Cas9-Expressing Jurkat cell pool

78070 2 million cells
EUR 795
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing Jurkat cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines.